found that three high-risk MDS patients displayed chromothripsis involving exclusively chromosome 13 and affecting some cancer genes: FLT3, BRCA2 and RB1, and all of them carried TP53 mutations [32]. The gene discussed is TP53; the disease is myelodysplastic syndrome.